Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Albuterol Sulfate Inhalation Aerosol vs Proair HFA in Healthy Volunteers
NCT04803734Phase 1Completed
- Sponsor
- Intech Biopharm Corporation
- Start
- Mar 2021
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of salbutamol in asthma (2 arms), sponsored by Intech Biopharm Corporation. Primary endpoints: Maximum Plasma Concentration at 24 hours, Area Under the Curve from time 0 to the last measurable concentration and 1 more. Started Mar 2021; status: completed.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04803734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04803734.